Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Giovanni Guaraldi, Marianna Meschiari et al.|Viruses|2023Cited by 5